Shunts and the Pulmonary Vasculature

Prevalence of PAH in CHD              
Presented by David Celermajer
University of Sydney
David Celermajer is the Head of the Discipline of Cardiology at the University of Sydney and Director of ACHD Services at the Royal Prince Alfred Hospital, where over 4000 ACHD patients are followed. An Editorial Board Member at Circulation, JACC, Heart and European Heart Journal, he has published over 400 papers in the international literature with an H-index of 90 and career citations over 40 000. His training was at the University of Sydney (where he won the University Medal), as a Rhodes Scholar in Oxford (studying the effects of alcohol on the heart using MRI!) and his PhD was from the University of London, in Childhood Origins of Atherosclerosis. His current interests include Early Detection of Pulmonary Vascular Disease and optimization of transition and later life care in ACHD.


Best Advice for Hemodynamic Assessment and  Interpretation in Patients with an ASD    
Presented by Rick Nishimura
Mayo Clinic

nishimura-rickDr. Nishimura is the Judd and Mary Morris Leighton Professor of Cardiovascular Diseases and Professor of Medicine at the Mayo Clinic College of Medicine.  He is a Master of the American College of Cardiology and Master of the American College of Physicians.  Dr. Nishimura’s research areas have involved the field of cardiovascular hemodynamics.  He has an active clinical practice with a particular interest in hypertrophic cardiomyopathy, valvular heart disease and pericardial disease.   He currently serves as Chair of the ACC/AHA Valvular Heart Disease Guideline Committee and has been on the ACC/AHA Parent Guideline Committee.  He has received the ACC Master Teacher Award, the American Heart Association Laennec Clinician/Educator Award, as well as the Mayo Clinic Distinguished Educator Award and the Mayo Clinic Distinguished Clinician Award.  He served as chair of education for the ACC in the past, was a member of the ACC Board  of Trustees, and was recently awarded the ACC Presidential Citation.


Pulmonary Vasoreactive Medications and Decisions about  Shunt Closure       
Presented by Elisa Bradley, MD
The Ohio State University

bradley-elisaDr. Elisa A. Bradley MD is an Assistant Professor of Medicine at The Ohio State University (Columbus, OH). She is a cardiologist and member of the Columbus Ohio Adult Congenital Heart (COACH) Program. She received her medical degree at the University of Illinois, completed Internal Medicine training at the University of Wisconsin, and general Cardiology fellowship at Washington University (St. Louis, MO). She then completed subspecialty adult congenital heart disease fellowship at The Ohio State University and Nationwide Children’s Hospital. Dr. Bradley’s research interests include: pulmonary hypertension in congenital heart disease, right ventricular function and failure, and Fontan associated liver disease.


QUERI ES and Lessons Learned Thus Far    
Presented by Curt Daniels
Nationwide Children’s Hospital.
Daniels pic
Curt J. Daniels, MD is a Professor of Clinical Internal Medicine and Pediatrics in the Division of Cardiology at The Ohio State University and the Division of Pediatric Cardiology at Nationwide Children’s Hospital. He is the Dottie Dohan Shepard Chair in Cardiovascular Medicine and the Director of the COACH program: Columbus Ohio Adult Congenital Heart Disease and Pulmonary Hypertension Program. Dr. Daniels is board certified in both pediatric cardiology and internal medicine cardiology. He serves on the Adult Congenital/Pediatric Cardiology Council and is the Co-Chair of the ACHD Working Group of the American College of Cardiology. In addition, Dr. Daniels serves as Chair of the Adult Congenital Heart Association Medical Advisory Board, and is Chair of the ACHA Program Accreditation Committee. Dr. Daniels is committed to education and has developed a fellowship training program for ACHD with over 10 fellow graduates, many of which have started new ACHD programs across the US. He has also worked to develop a subspecialty board certification in ACHD and currently serves as the Chair of the ABIM ACHD Subspecialty Board.  For the past 10 years Dr. Daniels has led a bi-monthly regional patient education lecture series for ACHD patients and has led the effort to provide a personalized electronic medical record for all patients followed in the ACHD program. Dr. Daniels has designed, implemented and successfully completed multiple ACHD research studies and presented his research nationally. In collaboration with colleagues from The Ohio State University and Nationwide Children’s Heart Center he has mentored fellows training thru the NIH T32 Training Grant entitled “Training in Congenital Heart Disease.” In 2011 Dr. Daniels was elected President of the International Society for ACHD with a focus on developing Global Health Initiatives for ACHD.  In 2014, he was selected as Co-Chair of the ACC/AHA ACHD Care Guidelines.


Disease Targeting Therapies in Eisenmenger Syndrome: Do They Make a Difference? If So, What Do They Do?
Presented by Alexander (Sasha) Opotowsky
Brigham and Women’s Hospital and Boston Children’s Hospital
Dr. Opotowsky is a staff member of the Boston Adult Congenital Heart (BACH) and Pulmonary Hypertension service at Brigham and Women’s Hospital and Boston Children’s Hospital, both in Boston. He completed medical school at Columbia University College of Physicians and Surgeons followed by training in Internal Medicine at Brigham and Women’s, adult Cardiology at the University of Pennsylvania, and an additional fellowship in pulmonary vascular disease and adult congenital heart disease with the BACH group. His research focuses on congenital heart                                          disease, exercise physiology, biomarkers and the pulmonary                                                circulation.

( average: 5.00 )